PNPLA3 genotype I148M is one of risk factors for developing HCC in Japanese CHC patients, and is one of risk factors for progress to cirrhosis in the patients without past history of interferon treatment. This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.